ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $163.94bn
- $191.33bn
- $44.33bn
U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel
U.S. STOCKS ON THE MOVE-Autodesk, Teledyne, Alphabet
Abbott falls after Q4 revenue misses estimates, downbeat Q1 profit forecast
U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital
Abbott falls after Q4 revenue misses estimates
Abbott Q4 sales misses analyst expectations, hurt by diagnostics unit's challenges
Abbott misses quarterly revenue estimates on weakness in diagnostics, nutrition (updated)
Brief: Abbott Q4 Adjusted EPS USD 1.5 Vs. IBES Estimate USD 1.5
Abbott misses quarterly revenue estimates on weakness in diagnostics segment
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
US FDA to limit regulation of health and fitness wearables, commissioner says
Medtech: Clear split between gainers and losers in 2025
Advisory: Alert from law firm on Exact Sciences-Abbott deal withdrawn
Brief: Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance
Brief: Abbott Increases Quarterly Dividend To 63 Cents Per Share
Press Digest: New York Times business news - December 5
Brief: Abbott Issues Medical Device Correction For Some Glucose Monitors In U.S.
Abbott issues US device correction for some glucose monitors over faulty readings risk
Street View: Brokerages downgrade Exact Sciences following acquisition by Abbott